AI Assistance for Cognitive Overload
Trial Summary
What is the purpose of this trial?
The goal of this study is to explore cognitive burden perceptions among physicians in relation to case report writing. Furthermore, this study evaluates the use of artificial intelligence (AI) assistance as a tool to reduce cognitive burden among providers preparing and submitting case reports. If an AI-tool is helpful in this setting, it may potentially help increase reporting of rare medical events and thereby improve the evidence base for care of these patient populations. This study will occur at a single time point which is expected to last approximately 2 hours. This session will include reviewing two rare tumor cases and then writing a clinical vignette with and without AI assistance.
Do I need to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems unlikely since the study focuses on cognitive tasks and AI assistance, not on medication effects.
What data supports the effectiveness of the treatment Artificial Intelligence for cognitive overload?
Is AI generally safe for use in healthcare settings?
How does the AI Assistance for Cognitive Overload treatment differ from other treatments for cognitive overload?
Research Team
Shivani Sud
Principal Investigator
UNC Lineberger Comprehensive Cancer Center
Eligibility Criteria
This trial is for physicians, medical students, or postdoctoral students. It's designed to see if AI can help reduce the mental effort they use when writing about rare tumor cases.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Single Session
Participants review two rare tumor cases and write a clinical vignette with and without AI assistance
Follow-up
Participants are monitored for cognitive workload and perceived cognitive load using NASA-TLX and SUS
Treatment Details
Interventions
- Artificial Intelligence
Find a Clinic Near You
Who Is Running the Clinical Trial?
UNC Lineberger Comprehensive Cancer Center
Lead Sponsor